Cargando…
Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells
The high-grade brain malignancy, glioblastoma multiforme (GBM), is one of the most aggressive tumours in central nervous system. The developing resistance against recent therapies and the recurrence rate of GBMs are extremely high. In spite several new ongoing trials, GBM therapies could not signifi...
Autores principales: | Petővári, Gábor, Dankó, Titanilla, Krencz, Ildikó, Hujber, Zoltán, Rajnai, Hajnalka, Vetlényi, Enikő, Raffay, Regina, Pápay, Judit, Jeney, András, Sebestyén, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109188/ https://www.ncbi.nlm.nih.gov/pubmed/31187466 http://dx.doi.org/10.1007/s12253-019-00677-2 |
Ejemplares similares
-
Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells
por: Petővári, Gábor, et al.
Publicado: (2018) -
GABA, glutamine, glutamate oxidation and succinic semialdehyde dehydrogenase expression in human gliomas
por: Hujber, Zoltán, et al.
Publicado: (2018) -
Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting
por: Dankó, Titanilla, et al.
Publicado: (2022) -
Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics
por: Krencz, Ildikó, et al.
Publicado: (2022) -
In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy
por: Petővári, Gábor, et al.
Publicado: (2020)